Regn investors have opportunity to lead regeneron pharmaceuticals, inc. securities fraud lawsuit with the schall law firm

Los angeles , jan. 27, 2025 /prnewswire/ -- the schall law firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against regeneron pharmaceuticals, inc. ("regeneron" or "the company") (nasdaq: regn) for violations of §§10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between november 2, 2023 and october 30, 2024, inclusive (the "class period"), are encouraged to contact the firm before march 10, 2025.
REGN Ratings Summary
REGN Quant Ranking